ÃֽŠÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
6¿ù [±âÃÊÀÇÇÐ] ¿¬±¸µ¿Çâ Å°¿öµå ³×Æ®¿öÅ© ºÐ¼®
±×¸² 1. ±âÃÊÀÇÇÐ 6¿ù Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå
ÀÇ°úÇко߿¡¼ ±âÃÊÀÇÇÐ 6¿ù ³í¹® ¹ßÇ¥´Â ÃÑ 1,102ÆíÀ¸·Î Àü¿ù 1,084Æí°ú ºñ½ÁÇÑ ¼öÁØÀ̾ú´Ù. ÀÌ °¡¿îµ¥ ±¹³» Àú³ÎÀ» ÅëÇÑ ¹ßÇ¥´Â ÀüüÀÇ 12.8%¿¡ ºÒ°úÇÏ¿´À¸¸ç ÇØ¿Ü Àú³ÎÀ» ÅëÇÑ ¹ßÇ¥°¡ 87.2%¸¦ Â÷ÁöÇÏ¿©, ±âÃÊÀÇÇÐ ºÐ¾ß¿¡¼´Â ÇØ¿Ü Àú³ÎÀ» ÅëÇÑ ¹ßÇ¥°¡ ±¹³» ¹ßÇ¥¿¡ ºñÇØ ¿ùµîÀÌ ¸¹À½À» ³ªÅ¸³»¾ú´Ù. 6¿ù ÀÇ°úÇÐ Àüü ³í¹® ¹ßÇ¥ Áß¿¡¼ ±âÃÊÀÇÇÐ ºÐ¾ß ³í¹®ÀÌ Â÷ÁöÇÏ´Â ºñÀ²Àº 34.3%¸¦ Â÷ÁöÇÏ¿´´Ù.
Ç¥ 1. 6¿ù ±âÃÊÀÇÇÐ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=1,102)
Å°¿öµå ¼øÀ§
|
±¹³» ±âÃÊÀÇÇÐ ¿¬±¸
|
±¹¿Ü ±âÃÊÀÇÇÐ ¿¬±¸
|
ÅëÇÕ ±âÃÊÀÇÇÐ Å°¿öµå
|
1
|
Role
|
Genes
|
Genes
|
2
|
Neoplasms
|
Neoplasms
|
Role
|
3
|
Population
|
Humans
|
Neoplasms
|
4
|
Women
|
Role
|
Humans
|
5
|
In Vitro Techniques
|
Risk
|
Economics
|
6
|
Inflammation
|
Economics
|
Risk
|
7
|
Vaccination
|
Attention
|
Attention
|
8
|
RNA
|
Drug
|
Drug
|
9
|
Learning
|
Death
|
Death
|
10
|
Risk
|
Efficiency
|
Population
|
±×¸² 2. ±¹³» 6¿ù ±âÃÊÀÇÇÐ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
±×¸² 3. ±¹¿Ü6¿ù ±âÃÊÀÇÇÐ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
Ç¥ 2. ±âÃÊÀÇÇÐ 6¿ù ÅäÇÈ ³×Æ®¿öÅ© ¸ðµ¨¸µ
Topic1
|
Topic2
|
Topic3
|
Topic4
|
Topic5
|
Attention
|
Genes
|
Drug
|
Role
|
Risk
|
Learning
|
DNA
|
COVID-19
|
Humans
|
Neoplasms
|
Sensitivity And Specificity
|
Genome
|
Economics
|
Neoplasms
|
Drug
|
Classification
|
Humans
|
Stability
|
Economics
|
Serum
|
Dataset
|
Role
|
Water
|
In Vitro Techniques
|
Pain
|
Role
|
Biofilms
|
Forecasting
|
Macrophages
|
Stroke
|
Serum
|
RNA
|
Technology
|
Bone And Bones
|
Death
|
Kidney
|
Antimicrobial
|
Vaccination
|
Stem Cells
|
Recurrence
|
Evaluation Studies As Topic
|
Family
|
Population
|
Death
|
Brain
|
Efficiency
|
Anti-Bacterial Agents
|
Efficiency
|
Inflammation
|
Depression
|
±×¸² 4. ±âÃÊÀÇÇÐ 6¿ù ÅäÇÈ Å°¿öµå ³×Æ®¿öÅ© ¿¬±¸µ¿Ç⠺м®
±âÃÊÀÇÇÐ ¿¬±¸µ¿Ç⠺м®¿¡ »ç¿ëµÈ ³í¹®µ¥ÀÌÅÍ´Â 2022³â 6¿ù¿¡ ¹ßÇ¥µÈ Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿Í NIH Æà¸Þµå(PubMed) µ¥ÀÌÅͺ£À̽º¿¡ À妽ºµÈ ³í¹®ÀڷḦ ÃßÃâÇÏ¿© ºÐ¼®ÇÏ¿´´Ù. ±âÃÊÀÇÇÐ ºÐ¾ß ±¹³» ¹× ±¹¿Ü Àú³Î¿¡ ³ªÅ¸³ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå´Â Ç¥ 1°ú °°ÀÌ Genes, Role, Neoplasms, Humans, Economics, Risk, Attention, Drug, Death, Population, In Vitro Techniques, Efficiency, COVID-19, Learning, Forecasting, Serum, Water, Inflammation, Stability µîÀ¸·Î ³ªÅ¸³µ´Ù.
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø
* º» ³»¿ëÀº MedRIC (www.medric.or.kr)ÀÇ ¿¬±¸µ¿Çâ¿¡¼ Á¦°øµÇ´Â ³»¿ëÀÔ´Ï´Ù.